These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 28448850
1. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins. Harden ME, Munger K. Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850 [Abstract] [Full Text] [Related]
2. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F, Wang N, Wang S, Yu F, Sun X, Yu X, Luo B, Zhao C, Wang Y. Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [Abstract] [Full Text] [Related]
3. Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles. Harden ME, Munger K. Virology; 2017 Aug; 508():63-69. PubMed ID: 28500882 [Abstract] [Full Text] [Related]
4. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells. He H, Liu X, Liu Y, Zhang M, Lai Y, Hao Y, Wang Q, Shi D, Wang N, Luo XG, Ma W, Zhang TC. J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30728257 [Abstract] [Full Text] [Related]
5. Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells. Shao Y, Shah PT, Su Q, Li S, Huang F, Wang J, Wang P, Wu C. Front Cell Infect Microbiol; 2024 Apr 15; 14():1459572. PubMed ID: 39411320 [Abstract] [Full Text] [Related]
6. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker. Fontecha N, Basaras M, Hernáez S, Andía D, Cisterna R. BMC Cancer; 2016 Nov 05; 16(1):852. PubMed ID: 27816058 [Abstract] [Full Text] [Related]
7. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma. Tian Q, Huang J, Zhang Q, Zhao J. Clin Exp Pharmacol Physiol; 2024 Jun 05; 51(6):e13864. PubMed ID: 38679464 [Abstract] [Full Text] [Related]
8. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer. Han MS, Lee JM, Kim SN, Kim JH, Kim HS. Biomed Res Int; 2018 Jun 05; 2018():1942867. PubMed ID: 30627542 [Abstract] [Full Text] [Related]
9. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer. Ma C, Zeng C, Jin L, Yang Y, Li P, Chen L, Wang J. Sci Rep; 2015 Nov 12; 5():16555. PubMed ID: 26560046 [Abstract] [Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). McFarlane M, MacDonald AI, Stevenson A, Graham SV. J Virol; 2015 May 12; 89(10):5276-87. PubMed ID: 25717103 [Abstract] [Full Text] [Related]
11. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo. Hu D, Zhou J, Wang F, Shi H, Li Y, Li B. Arch Gynecol Obstet; 2015 Dec 12; 292(6):1345-54. PubMed ID: 26093522 [Abstract] [Full Text] [Related]
12. Exploring the Role of E6 and E7 Oncoproteins in Cervical Oncogenesis through MBD2/3-NuRD Complex Chromatin Remodeling. Fudulu A, Diaconu CC, Iancu IV, Plesa A, Albulescu A, Bostan M, Socolov DG, Stoian IL, Balan R, Anton G, Botezatu A. Genes (Basel); 2024 Apr 27; 15(5):. PubMed ID: 38790189 [Abstract] [Full Text] [Related]
13. Human papillomavirus 16E6/E7 activates autophagy via Atg9B and LAMP1 in cervical cancer cells. Tingting C, Shizhou Y, Songfa Z, Junfen X, Weiguo L, Xiaodong C, Xing X. Cancer Med; 2019 Aug 27; 8(9):4404-4416. PubMed ID: 31215164 [Abstract] [Full Text] [Related]
14. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18. Díaz-Tejeda Y, Guido-Jiménez MC, López-Carbajal H, Amador-Molina A, Méndez-Martínez R, Gariglio-Vidal P, Lizano M, García-Carrancá A. Viruses; 2021 Jul 28; 13(8):. PubMed ID: 34452350 [Abstract] [Full Text] [Related]
15. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Kim YW, Chaturvedi PK, Chun SN, Lee YG, Ahn WS. Oncol Rep; 2015 Apr 28; 33(4):1675-82. PubMed ID: 25633640 [Abstract] [Full Text] [Related]
16. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers. Yew CW, Lee P, Chan WK, Lim VK, Tay SK, Tan TM, Deng LW. Cancer Res; 2011 Nov 01; 71(21):6696-707. PubMed ID: 21908553 [Abstract] [Full Text] [Related]
17. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway. Liu J, Zhao H, Zhang Q, Shi Z, Zhang Y, Zhao L, Ren Y, Ou R, Xu Y. Exp Cell Res; 2020 Nov 01; 396(1):112277. PubMed ID: 32918895 [Abstract] [Full Text] [Related]
18. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins. Yablonska S, Hoskins EE, Wells SI, Khan SA. Microrna; 2013 Nov 01; 2(1):2-13. PubMed ID: 25070710 [Abstract] [Full Text] [Related]
19. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16. Woodworth CD, Diefendorf LP, Jette DF, Mohammed A, Moses MA, Searleman SA, Stevens DA, Wilton KM, Mondal S. Virology; 2011 Dec 05; 421(1):19-27. PubMed ID: 21982220 [Abstract] [Full Text] [Related]
20. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA. Oncogene; 2008 Apr 17; 27(18):2575-82. PubMed ID: 17998940 [Abstract] [Full Text] [Related] Page: [Next] [New Search]